The BCBA Shortage Is Not Improving: What ABA Employers Must Do Right Now

A TYGES International report uncovers a staggering deficit of BCBAs, calling for urgent measures to address the autism care crisis in America.
Addressing the BCBA Shortage in Autism Care

Families with autistic children face long waits for therapy due to a significant shortage of qualified behavior analysts, as highlighted in a new analysis.
ABA Staff With Strong Soft Skills Get Better Outcomes — And Stay Longer

Enhancing soft skills in applied behavior analysis improves family satisfaction, client outcomes, and staff retention. This guide gives ABA organizations a framework for developing communication and professional skills alongside technical competency.
Barriers to In-Network Behavioral Health Care Persist

Despite the Mental Health Parity and Addiction Equity Act, significant barriers remain for patients seeking mental health care.
CMS ACCESS Model: What Behavioral Health Organizations Need to Hire to Participate

The CMS ACCESS model is a groundbreaking initiative aimed at value-based care in behavioral health, with major implications for providers.
TMS: The Future of Mental Health Care

This article discusses the growing relevance of TMS in treating treatment-resistant depression and the operational changes required for outpatient mental health clinics.
Key Trends Impacting Behavioral Health in 2024

A recent report highlights crucial trends regarding mental health treatment in the U.S., revealing disparities and economic implications of untreated disorders.
Challenges in Funding Integrated Care: Who Pays?

Integrated care promises better health outcomes but faces significant financing challenges. Experts discuss solutions.
Recover Now Merges with Widespread Wellness to Expand Services

Recover Now has merged with Widespread Wellness to expand its treatment capabilities into mental health services, aiming for greater service delivery.
White House to Expand Ibogaine Research for PTSD Treatment

The White House prepares an executive order to expand research into ibogaine’s potential use for PTSD, raising crucial safety discussions.